{
    "info": {
        "nct_id": "NCT03970226",
        "official_title": "A Phase 0/Feasibility Trial of Tocilizumab in Children and Adolescents With Newly- Diagnosed or Recurrent/Progressive Adamantinomatous Craniopharyngioma",
        "inclusion_criteria": "1. Age: ≥ 2 years and < 21 years\n2. Subjects may have received prior tocilizumab or other IL6 or IL6R inhibitor\n3. Organ Function Requirements\n\n   1. Adequate bone marrow function defined as:\n\n      * Platelet count ≥100,000/μl (transfusion independent)\n      * Absolute neutrophil count (ANC) ≥1500/μl\n   2. Adequate renal function defined as:\n\n      * Creatinine clearance or radioisotope GFR ≥70 ml/min/1.73 m2 or\n      * A serum creatinine based on age/gender as follows: (Age, Male, Female) 3 to < 6 years, 0.8, 0.8; 6 to < 10 years, 1, 1; 10 to < 13 years, 1.2, 1.2; 13 to < 16 years, 1.5, 1.4; 16 years to < 18 years, 1.7, 1.4\n   3. Adequate liver function defined as:\n\n      * SGOT (AST) and SGPT (ALT) <1.5x ULN for age\n4. Subjects must meet one of the following performance scores:\n\n   1. ECOG performance status scores of 0, 1, or 2;\n   2. Karnofsky score of ≥60 for patients > 16 years of age; or\n   3. Lansky score of ≥60 for patients ≤16 years of age\n5. Subjects of childbearing or child fathering potential must be willing to use a medically acceptable form of birth control, which includes abstinence, while being treated on this study.\n6. Informed consent and assent obtained as appropriate.\n\nExclusion Criteria\n\n1. Pregnant or breastfeeding\n2. Uncontrolled intercurrent illness including, but not limited to:\n\n   1. ongoing or active infection (including active tuberculosis)\n   2. symptomatic congestive heart failure\n   3. unstable angina pectoris\n   4. cardiac arrhythmia\n   5. psychiatric illness/social situations that would limit compliance with study requirements are not eligible.\n3. Known hypersensitivity or history of anaphylaxis to tocilizumab\n4. Received any live vaccinations within 3 months prior to start of therapy\n5. Evidence of metastatic disease or other cancer\n6. Inability to return for follow up visits or obtain required follow-up studies to assess toxicity of therapy\nHealthy volunteers allowed\nMust have minimum age of 2 Years\nMust have maximum age of 21 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": "Inclusion Criteria\n\nPhase 0 Eligibility:\n\n1. Tumor biopsy/resection and/or cyst aspiration planned for the clinical care of the patient independent of study participation by the treating pediatric neurosurgeon and neuro-oncologist\n2. Must meet one of the following criteria:\n\n   1. Presumed craniopharyngioma based on imaging features and best judgement of treating medical team (if newly diagnosed)\n   2. Previous histologically confirmed ACP that has progressed or recurred at the time of enrollment\n\nFeasibility Eligibility:\n\n1. Must meet one of the following criteria:\n\n   1. Recurrent or progressive* ACP treated with surgery alone without radiation\n   2. Recurrent or progressive* ACP treated with surgery and radiation\n\n      * Progressive disease for eligibility purposes will be defined as follows: Solid disease: any growth deemed progression based on discretion of the investigator regardless of timing from RT Cystic disease: must be at least 6 months from last day of RT. Patients demonstrating isolated cyst growth >6 months after RT must show a continued increase in the cystic component on two serial MRI scans performed at least 4 weeks apart OR at least partial reaccumulation of the cyst following one or more cyst aspirations.\n   3. Newly diagnosed, by histology or imaging ACP with unresectable residual cystic and/or solid disease that is measurable in 2 dimensions\n2. Subjects who participated in the Phase 0 portion and meet eligibility, may enroll in the Feasibility Phase of the study once open.\n\nOverall Study"
    },
    "inclusion_lines": [
        {
            "line": "3. Adequate liver function defined as:",
            "criterions": [
                {
                    "exact_snippets": "Adequate liver function",
                    "criterion": "liver function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Evidence of metastatic disease or other cancer",
            "criterions": [
                {
                    "exact_snippets": "Evidence of metastatic disease",
                    "criterion": "metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "other cancer",
                    "criterion": "other cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Uncontrolled intercurrent illness including, but not limited to:",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled intercurrent illness",
                    "criterion": "intercurrent illness",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. symptomatic congestive heart failure",
            "criterions": [
                {
                    "exact_snippets": "symptomatic congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "symptomatic"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Inability to return for follow up visits or obtain required follow-up studies to assess toxicity of therapy",
            "criterions": [
                {
                    "exact_snippets": "Inability to return for follow up visits",
                    "criterion": "ability to return for follow up visits",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "obtain required follow-up studies to assess toxicity of therapy",
                    "criterion": "ability to obtain required follow-up studies to assess toxicity of therapy",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Informed consent and assent obtained as appropriate.",
            "criterions": [
                {
                    "exact_snippets": "Informed consent ... obtained",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "obtained",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "assent obtained as appropriate",
                    "criterion": "assent",
                    "requirements": [
                        {
                            "requirement_type": "obtained",
                            "expected_value": "as appropriate"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Subjects of childbearing or child fathering potential must be willing to use a medically acceptable form of birth control, which includes abstinence, while being treated on this study.",
            "criterions": [
                {
                    "exact_snippets": "Subjects of childbearing or child fathering potential",
                    "criterion": "childbearing or child fathering potential",
                    "requirements": [
                        {
                            "requirement_type": "potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must be willing to use a medically acceptable form of birth control, which includes abstinence, while being treated on this study",
                    "criterion": "use of medically acceptable form of birth control",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "while being treated on this study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelet count ≥100,000/μl (transfusion independent)",
            "criterions": [
                {
                    "exact_snippets": "Platelet count ≥100,000/μl (transfusion independent)",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "/μl"
                            }
                        },
                        {
                            "requirement_type": "transfusion independence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Organ Function Requirements",
            "criterions": [
                {
                    "exact_snippets": "Organ Function Requirements",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "meets protocol-defined requirements"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 21 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 21 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 21,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A serum creatinine based on age/gender as follows: (Age, Male, Female) 3 to < 6 years, 0.8, 0.8; 6 to < 10 years, 1, 1; 10 to < 13 years, 1.2, 1.2; 13 to < 16 years, 1.5, 1.4; 16 years to < 18 years, 1.7, 1.4",
            "criterions": [
                {
                    "exact_snippets": "A serum creatinine based on age/gender as follows: (Age, Male, Female) 3 to < 6 years, 0.8, 0.8; 6 to < 10 years, 1, 1; 10 to < 13 years, 1.2, 1.2; 13 to < 16 years, 1.5, 1.4; 16 years to < 18 years, 1.7, 1.4",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "maximum value by age and gender",
                            "expected_value": [
                                "For males: 3 to <6 years: <=0.8 mg/dL; 6 to <10 years: <=1 mg/dL; 10 to <13 years: <=1.2 mg/dL; 13 to <16 years: <=1.5 mg/dL; 16 to <18 years: <=1.7 mg/dL",
                                "For females: 3 to <6 years: <=0.8 mg/dL; 6 to <10 years: <=1 mg/dL; 10 to <13 years: <=1.2 mg/dL; 13 to <16 years: <=1.4 mg/dL; 16 to <18 years: <=1.4 mg/dL"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute neutrophil count (ANC) ≥1500/μl",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count (ANC) ≥1500/μl",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "/μl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. ECOG performance status scores of 0, 1, or 2;",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status scores of 0, 1, or 2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": [
                                "0",
                                "1",
                                "2"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Lansky score of ≥60 for patients ≤16 years of age",
            "criterions": [
                {
                    "exact_snippets": "Lansky score of ≥60 for patients ≤16 years of age",
                    "criterion": "Lansky score",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "N/A"
                            }
                        },
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": "<=",
                                "value": 16,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Age: ≥ 2 years and < 21 years",
            "criterions": [
                {
                    "exact_snippets": "Age: ≥ 2 years and < 21 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "years"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 21,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Creatinine clearance or radioisotope GFR ≥70 ml/min/1.73 m2 or",
            "criterions": [
                {
                    "exact_snippets": "Creatinine clearance ... ≥70 ml/min/1.73 m2",
                    "criterion": "creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 70,
                                "unit": "ml/min/1.73 m2"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "radioisotope GFR ≥70 ml/min/1.73 m2",
                    "criterion": "radioisotope GFR",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 70,
                                "unit": "ml/min/1.73 m2"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Known hypersensitivity or history of anaphylaxis to tocilizumab",
            "criterions": [
                {
                    "exact_snippets": "Known hypersensitivity ... to tocilizumab",
                    "criterion": "hypersensitivity to tocilizumab",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of anaphylaxis to tocilizumab",
                    "criterion": "anaphylaxis to tocilizumab",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* SGOT (AST) and SGPT (ALT) <1.5x ULN for age",
            "criterions": [
                {
                    "exact_snippets": "SGOT (AST) ... <1.5x ULN for age",
                    "criterion": "SGOT (AST) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "x ULN for age"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "SGPT (ALT) <1.5x ULN for age",
                    "criterion": "SGPT (ALT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "x ULN for age"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Received any live vaccinations within 3 months prior to start of therapy",
            "criterions": [
                {
                    "exact_snippets": "Received any live vaccinations within 3 months prior to start of therapy",
                    "criterion": "live vaccinations",
                    "requirements": [
                        {
                            "requirement_type": "receipt within time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months prior to start of therapy"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. cardiac arrhythmia",
            "criterions": [
                {
                    "exact_snippets": "cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Karnofsky score of ≥60 for patients > 16 years of age; or",
            "criterions": [
                {
                    "exact_snippets": "Karnofsky score of ≥60 for patients > 16 years of age",
                    "criterion": "Karnofsky score",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": ""
                            }
                        },
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">",
                                "value": 16,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Pregnant or breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. unstable angina pectoris",
            "criterions": [
                {
                    "exact_snippets": "unstable angina pectoris",
                    "criterion": "angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": "unstable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 2 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 2 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Adequate renal function defined as:",
            "criterions": [
                {
                    "exact_snippets": "Adequate renal function",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Adequate bone marrow function defined as:",
            "criterions": [
                {
                    "exact_snippets": "Adequate bone marrow function",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Subjects may have received prior tocilizumab or other IL6 or IL6R inhibitor",
            "criterions": [
                {
                    "exact_snippets": "Subjects may have received prior tocilizumab",
                    "criterion": "prior tocilizumab treatment",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Subjects may have received ... other IL6 or IL6R inhibitor",
                    "criterion": "prior IL6 or IL6R inhibitor treatment",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Subjects must meet one of the following performance scores:",
            "criterions": [
                {
                    "exact_snippets": "Subjects must meet one of the following performance scores",
                    "criterion": "performance score",
                    "requirements": [
                        {
                            "requirement_type": "meets specified score",
                            "expected_value": "one of the following (not specified in this line)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. psychiatric illness/social situations that would limit compliance with study requirements are not eligible.",
            "criterions": [
                {
                    "exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "psychiatric illness",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "social situations",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. ongoing or active infection (including active tuberculosis)",
            "criterions": [
                {
                    "exact_snippets": "ongoing or active infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "ongoing",
                                "active"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "active tuberculosis",
                    "criterion": "tuberculosis",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [
        {
            "line": "3. Newly diagnosed, by histology or imaging ACP with unresectable residual cystic and/or solid disease that is measurable in 2 dimensions",
            "criterions": [
                {
                    "exact_snippets": "Newly diagnosed",
                    "criterion": "diagnosis status",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": "newly diagnosed"
                        }
                    ]
                },
                {
                    "exact_snippets": "by histology or imaging",
                    "criterion": "diagnosis confirmation method",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histology",
                                "imaging"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "ACP",
                    "criterion": "disease type",
                    "requirements": [
                        {
                            "requirement_type": "disease",
                            "expected_value": "ACP"
                        }
                    ]
                },
                {
                    "exact_snippets": "unresectable residual cystic and/or solid disease",
                    "criterion": "disease resectability",
                    "requirements": [
                        {
                            "requirement_type": "resectability",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "measurable in 2 dimensions",
                    "criterion": "disease measurability",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": "measurable in 2 dimensions"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Subjects who participated in the Phase 0 portion and meet eligibility, may enroll in the Feasibility Phase of the study once open.",
            "criterions": [
                {
                    "exact_snippets": "Subjects who participated in the Phase 0 portion",
                    "criterion": "participation in Phase 0 portion",
                    "requirements": [
                        {
                            "requirement_type": "participation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "meet eligibility",
                    "criterion": "meeting eligibility criteria for Feasibility Phase",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Recurrent or progressive* ACP treated with surgery alone without radiation",
            "criterions": [
                {
                    "exact_snippets": "Recurrent or progressive* ACP",
                    "criterion": "ACP (adamantinomatous craniopharyngioma)",
                    "requirements": [
                        {
                            "requirement_type": "disease status",
                            "expected_value": [
                                "recurrent",
                                "progressive"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "treated with surgery alone without radiation",
                    "criterion": "prior treatment",
                    "requirements": [
                        {
                            "requirement_type": "surgery",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "radiation",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Presumed craniopharyngioma based on imaging features and best judgement of treating medical team (if newly diagnosed)",
            "criterions": [
                {
                    "exact_snippets": "Presumed craniopharyngioma",
                    "criterion": "craniopharyngioma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_status",
                            "expected_value": "presumed"
                        }
                    ]
                },
                {
                    "exact_snippets": "based on imaging features",
                    "criterion": "imaging features consistent with craniopharyngioma",
                    "requirements": [
                        {
                            "requirement_type": "consistency_with_craniopharyngioma",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "best judgement of treating medical team",
                    "criterion": "treating medical team judgement",
                    "requirements": [
                        {
                            "requirement_type": "judgement_supports_craniopharyngioma",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "if newly diagnosed",
                    "criterion": "diagnosis status",
                    "requirements": [
                        {
                            "requirement_type": "newly diagnosed",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Progressive disease for eligibility purposes will be defined as follows: Solid disease: any growth deemed progression based on discretion of the investigator regardless of timing from RT Cystic disease: must be at least 6 months from last day of RT. Patients demonstrating isolated cyst growth >6 months after RT must show a continued increase in the cystic component on two serial MRI scans performed at least 4 weeks apart OR at least partial reaccumulation of the cyst following one or more cyst aspirations.",
            "criterions": [
                {
                    "exact_snippets": "Solid disease: any growth deemed progression based on discretion of the investigator regardless of timing from RT",
                    "criterion": "solid disease progression",
                    "requirements": [
                        {
                            "requirement_type": "progression determination",
                            "expected_value": "any growth deemed progression based on discretion of the investigator"
                        },
                        {
                            "requirement_type": "timing from RT",
                            "expected_value": "regardless of timing from RT"
                        }
                    ]
                },
                {
                    "exact_snippets": "Cystic disease: must be at least 6 months from last day of RT",
                    "criterion": "cystic disease progression",
                    "requirements": [
                        {
                            "requirement_type": "time from last day of RT",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients demonstrating isolated cyst growth >6 months after RT must show a continued increase in the cystic component on two serial MRI scans performed at least 4 weeks apart",
                    "criterion": "isolated cyst growth progression (after RT)",
                    "requirements": [
                        {
                            "requirement_type": "time from RT",
                            "expected_value": {
                                "operator": ">",
                                "value": 6,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "continued increase in cystic component",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "number of MRI scans",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "scans"
                            }
                        },
                        {
                            "requirement_type": "interval between MRI scans",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "at least partial reaccumulation of the cyst following one or more cyst aspirations",
                    "criterion": "cyst reaccumulation after aspiration",
                    "requirements": [
                        {
                            "requirement_type": "partial reaccumulation after aspiration",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "number of cyst aspirations",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "aspirations"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Recurrent or progressive* ACP treated with surgery and radiation",
            "criterions": [
                {
                    "exact_snippets": "Recurrent or progressive* ACP",
                    "criterion": "ACP (adamantinomatous craniopharyngioma)",
                    "requirements": [
                        {
                            "requirement_type": "disease status",
                            "expected_value": [
                                "recurrent",
                                "progressive"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "treated with surgery and radiation",
                    "criterion": "prior treatment",
                    "requirements": [
                        {
                            "requirement_type": "treatment type",
                            "expected_value": [
                                "surgery",
                                "radiation"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Previous histologically confirmed ACP that has progressed or recurred at the time of enrollment",
            "criterions": [
                {
                    "exact_snippets": "Previous histologically confirmed ACP",
                    "criterion": "ACP diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "has progressed or recurred at the time of enrollment",
                    "criterion": "ACP disease status",
                    "requirements": [
                        {
                            "requirement_type": "progression or recurrence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at the time of enrollment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Feasibility Eligibility:",
            "criterions": [
                {
                    "exact_snippets": "Feasibility Eligibility",
                    "criterion": "feasibility eligibility",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "feasibility eligibility (unspecified)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Tumor biopsy/resection and/or cyst aspiration planned for the clinical care of the patient independent of study participation by the treating pediatric neurosurgeon and neuro-oncologist",
            "criterions": [
                {
                    "exact_snippets": "Tumor biopsy/resection and/or cyst aspiration planned for the clinical care of the patient independent of study participation by the treating pediatric neurosurgeon and neuro-oncologist",
                    "criterion": "tumor biopsy, resection, or cyst aspiration",
                    "requirements": [
                        {
                            "requirement_type": "planned for clinical care",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "independent of study participation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "planned by",
                            "expected_value": [
                                "treating pediatric neurosurgeon",
                                "neuro-oncologist"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [
        {
            "line": "Exclusion Criteria",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": [
        {
            "line": "Phase 0 Eligibility:",
            "criterions": []
        },
        {
            "line": "Overall Study",
            "criterions": []
        },
        {
            "line": "1. Must meet one of the following criteria:",
            "criterions": []
        },
        {
            "line": "2. Must meet one of the following criteria:",
            "criterions": []
        },
        {
            "line": "Inclusion Criteria",
            "criterions": []
        }
    ]
}